Innovate UK grants £4m to four companies to evaluate biomarkers for dementia The progressive neurodegenerative disease affects more than 55 million people globally
Novo Nordisk to open new AI hub in UK for drug discovery The new hub will be located in the King’s Cross Knowledge Quarter, London